Related Experiment Video
Updated: Aug 12, 2025

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
Published on: April 13, 2018
Oncogene-like addiction to aneuploidy in human cancers
Vishruth Girish1,2, Asad A Lakhani3, Christine M Scaduto3
1Yale University School of Medicine, New Haven, CT 06511.
Abstract:
Most cancers exhibit aneuploidy, but its functional significance in tumor development is controversial. Here, we describe ReDACT (Restoring Disomy in Aneuploid cells using CRISPR Targeting), a set of chromosome engineering tools that allow us to eliminate specific aneuploidies from cancer genomes. Using ReDACT, we created a panel of isogenic cells that have or lack common aneuploidies, and we demonstrate that trisomy of chromosome 1q is required for malignant growth in cancers harboring this alteration. Mechanistically, gaining chromosome 1q increases the expression of MDM4 and suppresses TP53 signaling, and we show that TP53 mutations are mutually-exclusive with 1q aneuploidy in human cancers. Thus, specific aneuploidies play essential roles in tumorigenesis, raising the possibility that targeting these "aneuploidy addictions" could represent a novel approach for cancer treatment.
Insights
Aneuploidy, an abnormal chromosome number in cancer, is crucial for tumor growth. Researchers developed tools to remove specific aneuploidies, revealing chromosome 1q gain drives cancer by affecting MDM4 and TP53 signaling.
Area of Science:
- Cancer biology
- Genomics
- Chromosomal instability
Background:
- Aneuploidy is common in cancers, but its role in tumor development remains debated.
- Understanding the functional impact of specific aneuploidies is critical for cancer research.
Approach:
- Developed ReDACT (Restoring Disomy in Aneuploid cells using CRISPR Targeting), a CRISPR-based toolset for precise chromosome engineering in cancer cells.
- Created isogenic cancer cell lines with and without specific aneuploidies, including chromosome 1q trisomy.
- Investigated the mechanistic link between 1q gain, MDM4 expression, and TP53 pathway suppression.
Key Points:
- Trisomy of chromosome 1q is essential for the malignant growth of cancers with this alteration.
- Chromosome 1q gain leads to increased MDM4 expression and suppressed TP53 signaling.
- TP53 mutations and 1q aneuploidy are mutually exclusive in human cancers, suggesting distinct oncogenic pathways.
Conclusions:
- Specific aneuploidies, termed "aneuploidy addictions," play essential roles in tumorigenesis.
- Targeting these aneuploidy addictions presents a potential novel therapeutic strategy for cancer treatment.
Related Concept Videos
Nondisjunction
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

